{"id":"NCT01005719","sponsor":"Bayer","briefTitle":"Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)","officialTitle":"Randomized, Crossover, Pharmacodynamic Study Comparing the Effects of Two Proton Pump Inhibitors","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09","primaryCompletion":"2010-01","completion":"2010-01","firstPosted":"2009-11-02","resultsPosted":"2011-01-28","lastUpdate":"2015-03-11"},"enrollment":63,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Human Experimentation"],"interventions":[{"type":"DRUG","name":"Zegerid","otherNames":["omeprazole/sodium bicarbonate, SCH 900934"]},{"type":"DRUG","name":"Prevacid®","otherNames":["lansoprazole"]}],"arms":[{"label":"Zegerid","type":"EXPERIMENTAL"},{"label":"Prevacid®","type":"ACTIVE_COMPARATOR"},{"label":"No treatment","type":"NO_INTERVENTION"}],"summary":"This study will determine differences between Proton Pump Inhibitors (PPI) formulations relative to their effects on gastric acidity.","primaryOutcome":{"measure":"Achievement of Sustained Difference in Inhibition of Intragastric Acidity Based on Median pH Values Between the Two Active Study Treatments at Steady-state on Day 7","timeFrame":"Treatment dose to 4-hr post-dose on Day 7","effectByArm":[{"arm":"Zegerid","deltaMin":2.6,"sd":null},{"arm":"Prevacid®","deltaMin":1.82,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0242"},{"comp":"OG000 vs OG001","p":"0.0270"},{"comp":"OG000 vs OG001","p":"0.0067"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":12},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":60},"commonTop":["Headache","Constipation","Flatulence","Dizziness","Vomiting"]}}